Ever wonder how surgeons choose the right hip implant to use during surgery? There is a huge range of possible prosthesis combinations available for orthopedic surgeons to choose when they perform total hip arthroplasties. In 2000, the National Institute for Health and Care Excellence (NICE) established a 10 year revision rate benchmark of 10% for all hip  implants, meaning it was OK if 10% of a specific hip implant device was revised within 10 years. Due to the catastrophic failures and subsequent voluntary recalls of devices like the DePuy ASR, Stryker Rejuvenate and ABGII , NICE recently determined that this international benchmark for revision rates must be revisited so that poorly performing devices can be phased out. The authors of this study retrospectively reviewed the National Joint Registry of England and Wales to compare the 10 year revision rates for the most frequently used types of hip implants and prosthesis combinations. They found that all of the revision rates were less than 5% and supported NICE’s reduction of the international revision rate guideline from 10% to 5%. These authors also found that the regulation of new devices should be considered a priority as loose regulatory mechanisms have allowed a very large number of hip device brands to come into routine use without strict monitoring.

See Kandala, N-B et al. Setting benchmark revision rates for total hip replacement: analysis of registry evidence, BMJ, March 9, 2015

Weisman, Kennedy and Berris is currently serving on the leadership of national litigation involving DePuy’s ASR and Stryker’s Rejuvenate and ABGII devices. The firm has extensive experience in handling lawsuits against orthopedic device manufacturers and has been extremely successful in obtaining just compensation from clients across the country for pain, suffering and lost wages resulting from failed implants. If you or someone you know has experienced such a failure, attorneys at Weisman Kennedy and Berris would be happy to answer any questions you might have about available rights.